Community acquired acute bacterial meningitis in children and adults: An 11-year survey in a community hospital in Israel

2008 ◽  
Vol 19 (6) ◽  
pp. 421-426 ◽  
Author(s):  
J. Mishal ◽  
A. Embon ◽  
A. Darawshe ◽  
M. Kidon ◽  
E. Magen
2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Roney Santos Coimbra ◽  
Bruno Frederico Aguilar Calegare ◽  
Talitah Michel Sanchez Candiani ◽  
Vânia D’Almeida

PEDIATRICS ◽  
1960 ◽  
Vol 25 (5) ◽  
pp. 742-747
Author(s):  
Robert J. Haggerty ◽  
Mohsen Ziai

A controlled study of the treatment of bacterial meningitis with single and multiple, potentially antagonistic antimicrobial drugs was undertaken. Sixty-five patients received a single and 71 received several drugs in combination. The two groups were generally comparable. There was no significant difference in the results: that is antagonism could not be demonstrated in this clinical study. It seems reasonable to recommend that, in patients over 1 month of age with acute primary bacterial meningitis in whom an etiologic agent cannot be promptly identified, the use of multiple drugs aimed at the three most likely organisms (pneumococcus, meningococcus, H. influenzae) can be employed without danger of clinically apparent antagonism.


PEDIATRICS ◽  
1986 ◽  
Vol 78 (1) ◽  
pp. 21-25
Author(s):  
T. Jadavji ◽  
W. D. Biggar ◽  
R. Gold ◽  
C. G. Prober

The sequelae of acute bacterial meningitis in children who were treated with ampicillin or chloramphenicol for seven days during the period January 1979 to June 1983 were assessed prospectively. The 235 patients (117 boys and 118 girls) ranged in age from four days to 18 years (mean 26.4 months). Haemophilus influenzae type b was isolated in 70% of patients, Streptococcus pneumoniae in 20%, and Neisseria meningitidis in 10%. The mortality rate was 6.4%. No relapses occurred. Of the 220 survivors, 171 had neurologic psychometric, audiologic, and ophthalmologic assessments performed for a minimum of 1 year following their illness. One hundred thirty-six (80%) children had no detectable sequelae; 20% had mild to severe handicaps. The frequency of sequelae was greatest among children with S pneumoniae meningitis (57%) and least among children with N meningitidis (0%). The sequelae observed included: sensorineural hearing loss (12.9%), developmental delay (5.3%), speech defect (4.7%), motor defect (3.0%), hydrocephalus (1.7%), and seizure disorder (1%). The frequency of observed sequelae among these patients is similar to that previously reported in children treated for ten to 14 days. Our findings indicate that seven days of intravenous antibiotic therapy is adequate for the treatment of bacterial meningitis in children.


The Lancet ◽  
2001 ◽  
Vol 357 (9270) ◽  
pp. 1753-1757 ◽  
Author(s):  
James A Berkley ◽  
Isiah Mwangi ◽  
Caroline J Ngetsa ◽  
Salim Mwarumba ◽  
Brett S Lowe ◽  
...  

2013 ◽  
Vol 163 (1) ◽  
pp. S86-S91.e1 ◽  
Author(s):  
Asif Raza Khowaja ◽  
Syed Mohiuddin ◽  
Adam L. Cohen ◽  
Ahmed Khalid ◽  
Usma Mehmood ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document